-IANS The United States has asked the World Trade Organization (WTO) to rule on its assertion that India's restrictions on imports of US poultry meat and chicken eggs violates its WTO obligations. The US request to WTO to set up a dispute settlement panel was filed Monday after consultations with India on April 16-17, the first necessary step in pursuing a case, failed to resolve the US concerns, US Trade Representative (USTR)...
More »SEARCH RESULT
UNDP development report biased: India-Nitin Sethi
The government has taken exception to the `biases' in the United NationsDevelopment Programme's (UNDP) Asia Pacific Human Development report, titled, One Planet, which was released on Thursday. UNDP, required to play a neutral role in international governance, has recommended that India and other countries in the Asia Pacific region take greater responsibility to reduce emissions and warned that 'inclusive growth' would increase emissions, a trade-off that India cannot afford. Pointing...
More »Government to consult parties on grain storage
-The Economic Times The story of rotting foodgrains and hunger rocked the Lok Sabha yet again on Wednesday morning, prompting the government to say it was ready for consultations with political parties to find a long-term solution to the problem of storage facilities. Finance minister Pranab Mukherjee gave this assurance when an angry Opposition sought greater availability of jute sacks for wheat before the monsoon. BJP and its ally JD(U) have been...
More »Bayer to challenge Cipla’s decision to cut price of cancer drug
-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...
More »A healthier India: Need to resolve conflict between drug price controls, innovation and affordable healthcare-David Taylor
The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...
More »